The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP).
 
Emily J. Gallagher
Consulting or Advisory Role - Novartis; Seagen; SynDevRx
 
Heather Moore
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Novartis; Seagen
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Incyte; Innovaderm; Janssen; L'Oreal; La Roche-Posay; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; La Roche-Posay; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris; National Jewish Health (Inst); Novartis (Inst); Novocure; Paxman; US Biotest
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm
 
Susan Faye Dent
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
 
Azeez Farooki
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Novartis
 
Marcus D. Goncalves
Stock and Other Ownership Interests - Faeth Therapeutics
Honoraria - BridgeBio Pharma; Novartis; Pfizer; Scorpion Therapeutics
Consulting or Advisory Role - Scorpion Therapeutics
Patents, Royalties, Other Intellectual Property - Weill Cornell Medical College
 
Claudine Isaacs
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Eisai; Genentech/Roche; Gilead Sciences; Ion Solutions; Novartis; Pfizer; Puma Biotechnology; Sanofi/Aventis; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Other Relationship - Side-Out Foundation
 
Abigail Johnston
No Relationships to Disclose
 
Dejan Juric
Stock and Other Ownership Interests - PIC Therapeutics; Relay Therapeutics; Vibliome Therapeutics
Consulting or Advisory Role - Eisai; EMD Serono; Genentech; Ipsen; MapKure; Novartis; Petra Pharma; PIC Therapeutics; Relay Therapeutics; Silverback Therapeutics; Syros Pharmaceuticals; Vibliome Therapeutics
Research Funding - Amgen (Inst); Eisai (Inst); EMD Serono (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); InventisBio (Inst); Novartis (Inst); Pfizer (Inst); Placon (Inst); Syros Pharmaceuticals (Inst); Takeda (Inst); Takeda (Inst)
 
Zoe Quandt
Consulting or Advisory Role - Novartis
 
Laura Spring
Consulting or Advisory Role - Avrobio; Novartis; Puma Biotechnology
Research Funding - Merck (Inst); Philips Healthcare (Inst)
 
Brian Berman
Stock and Other Ownership Interests - Berg Pharma
Consulting or Advisory Role - Aiviva Biopharma; Almirall; Berg Pharma; Lemonex; Mediwound; MINO Labs; Pulse; Sensus; Sirnaomics
Speakers' Bureau - Almirall; Sensus
Research Funding - MINO Labs (Inst); Sirnaomics (Inst)
Travel, Accommodations, Expenses - Berg Pharma
 
Melanie Decker
Honoraria - Partnership for Health Analytic Research
 
Gabriel N. Hortobagyi
Consulting or Advisory Role - Novartis; Seagan
Research Funding - Novartis (Inst)
 
Benjamin Kaffenberger
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Novartis; Novocure
Research Funding - Biogen; Dermatology Foundation; InflaRx; Lilly; OnQuality Pharmaceuticals
Patents, Royalties, Other Intellectual Property - ZitGenius
Expert Testimony - Emory Healthcare
 
Bernice Y. Kwong
Consulting or Advisory Role - Novartis; Oncoderm
 
Timothy J. Pluard
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Genentech; Gilead Sciences; H3 Biomedicine; Macrogenics; Novartis; Pfizer; Seagen
Speakers' Bureau - Genentech/Roche; Gilead Sciences; Novartis; Seagen
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); DAEHWA Pharmaceutical (Inst); Dantari (Inst); G1 Therapeutics (Inst); H3 Biomedicine (Inst); HiberCell (Inst); Olema Pharmaceuticals (Inst); Orinove (Inst); Orinove (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst); Zymeworks (Inst)
 
Ruta D. Rao
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Immunomedics; Novartis; Puma Biotechnology; Seagen
 
Lee S. Schwartzberg
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Coherus Biosciences; Genentech; GlaxoSmithKline; Helsinn Therapeutics; Illumina; Lilly; Mirati Therapeutics; Myriad Genetics; Napo Pharmaceuticals; Pfizer; Sanofi; Spectrum Pharmaceuticals
Speakers' Bureau - Coherus Biosciences; Merck; Puma Biotechnology; Seagen
 
Michael S. Broder
Other Relationship - Akcea Therapeutics (Inst); Amgen (Inst); BioMarin (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dompe US (Inst); Eisai (Inst); Exact Sciences (Inst); Genentech (Inst); Genzyme (Inst); GRAIL (Inst); Greenwich Biosciences (Inst); Innovation and Value Initiative (Inst); Jazz Pharmaceuticals (Inst); Mirum Pharmaceuticals (Inst); Novartis (Inst); Otsuka (Inst); PhRMA Foundation (Inst); Prothena (Inst); Recordati (Inst); Regeneron (Inst); Sanofi (Inst); Sunovion (Inst); Takeda (Inst); Veana Therapeutics (Inst)